Stay updated with breaking news from Diffusion Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN – Get Rating) was the recipient of a large growth in short interest in the month of April. As of April 30th, there was short interest totalling 3,900 shares, a growth of 18.2% from the April 15th total of 3,300 shares. Based on an average trading volume of 6,800 shares, the […]
Research analysts at StockNews.com assumed coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) in a report issued on Saturday. The firm set a “hold” rating on the stock. Diffusion Pharmaceuticals Stock Up 3.3 % Shares of DFFN opened at $4.06 on Friday. Diffusion Pharmaceuticals has a 52-week low of $3.65 and a 52-week […]
Stock Analysts’ new coverage for Saturday, May 13th: StockNews.com initiated coverage on shares of Adamis Pharmaceuticals (NASDAQ:ADMP). StockNews.com issued a hold rating on the stock. StockNews.com initiated coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE). They issued a hold rating on the stock. StockNews.com started coverage on shares of Aerojet Rocketdyne (NYSE:AJRD). StockNews.com issued a hold […]
/PRNewswire/ -- EIP Pharma Inc., a clinical stage company focused on developing treatments for neurodegenerative diseases, today announced that the Company's...
EIP Pharma to Present at JMP Securities Life Sciences Conference BOSTON, MA - May 11, 2023 - EIP Pharma Inc., a clinical stage company focused on developing treatments for... | May 11, 2023